Medical Science News

RSS

Continuous boosting of natural painkiller shuts down brain cell receptor response

ERepeatedly boosting brain levels of one natural painkiller soon shuts down the brain cell receptors that respond to it, so that the painkilling effect is lost, according to a surprising new study led by Scripps Research Institute and Virginia Commonwealth University scientists. The study has important implications for drug development.

25 Aug 2010

Bisphenol A chemical may shorten reproductive lifespan in women: Research

A study posted today (Wednesday, August 25) at the online site of the journal Biology of Reproduction reports that exposure of pregnant female mice to the endocrine-disrupting chemical bisphenol A may produce adverse reproductive consequences on gene expression in fetal ovaries as early as 12 hours after the mother has first been exposed to the chemical.

25 Aug 2010

Human umbilical cord blood cells appear to protect astrocytes from cell death: Research

Human umbilical cord blood cells (HUCB) used to treat cultured rat brain cells (astrocytes) deprived of oxygen appear to protect astrocytes from cell death after stroke-like damage, reports a team of researchers from the University of South Florida (USF) Department of Neurosurgery and Brain Repair.

25 Aug 2010

CRT, Bayer Schering Pharma partner to study new leptin antagonist peptides in gynaecological, oncological diseases

Cancer Research Technology has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynaecological diseases, including cancer.

25 Aug 2010

Vitamin D2 in AbM mushroom can neutralize oxidative stress: Research

Total Nutraceutical Solutions, Inc., announced that it has completed a research study comparing the therapeutic effect of single nutrient forms of synthetic Vitamin D3 and D2 versus natural Vitamin D2 within a whole food. The study focused on the control of Paraquat induced oxidative stress/biologic death.

25 Aug 2010

Study identifies four genetic variants associated with ESRD disease in Chinese diabetic patients

Examination of a gene involved in cell signaling finds that four common variants of this gene are associated with the development of end-stage renal disease in Chinese patients with type 2 diabetes, according to a study in the August 25 issue of JAMA.

25 Aug 2010

Water improves health and reverses aging process

Forget everything you thought you knew about aging! The Water Secret: The Cellular Breakthrough to Look and Feel 10 Years Younger, a new health how-to guide by Howard Murad, M.D., reveals how readers can take charge of their health by addressing cells' most basic need — water. Detailing a new, breakthrough theory that establishes cellular water loss as the common pathway to disease and aging, Dr. Murad gives readers a complete, easy-to-use, 10-step action plan that will improve their overall health and reverse the aging process.

25 Aug 2010

Agilent Technologies introduces SureSelect Human All Exon v2 Target Enrichment kit for cancer assay

Agilent Technologies Inc.today introduced the SureSelect Human All Exon v2 Target Enrichment kit, which was developed in close collaboration with the Broad Institute of MIT and Harvard. The kit, the 15th SureSelect product in Agilent's portfolio, is a single tube assay that allows researchers to streamline experiments by sequencing the expressed genome while discarding regions not of interest.

25 Aug 2010

Researchers identify specific gene responsible for Kuf's disease

A North Carolina State University researcher has helped to locate and identify a gene responsible for a fatal neurodegenerative disease that affects American Staffordshire terriers. This same gene may be responsible for a similar rare, fatal disease in humans. Its discovery will lead to improved screening and diagnosis of the disease in dogs and is the first step in working toward a cure for both canines and humans.

25 Aug 2010

Mayo researchers develop new laboratory cell lines to study anaplastic thyroid cancer

To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world. Up to half of the cell lines that were supposed to originate from patients with this rare thyroid cancer were either colon or melanoma cancer.

25 Aug 2010

Fluoridation exposure during childhood prevents adult tooth loss

Children drinking water with added fluoride helps dental health in adulthood decades later, a new study finds.

25 Aug 2010

New TRIM5α-based treatments can knock out HIV in humans: Research

Using a $225,000 microscope, researchers have identified the key components of a protein called TRIM5α that destroys HIV in rhesus monkeys.The finding could lead to new TRIM5α-based treatments that would knock out HIV in humans, said senior researcher Edward M. Campbell, PhD, of Loyola University Health System.

25 Aug 2010

Water soluble extract of cinnamon reduces diabetes and heart disease risk

A study led by U.S. Department of Agriculture (USDA) chemist Richard Anderson suggests that a water soluble extract of cinnamon, which contains antioxidative compounds, could help reduce risk factors associated with diabetes and heart disease.

25 Aug 2010

Increased levels of Oxytocin hormone fosters trust, increases generosity

Oxytocin (OT) is a hormone that plays an important role in social behavior-it has even been nicknamed "the love hormone" and "liquid trust." Increased levels of OT have been associated with greater caring, generosity, and trust.

25 Aug 2010

Researchers identify molecular signals that impact male fertility: Research

Male infertility is a common medical problem, affecting millions of men in the United States annually. Its causes include an inability to make productive sperm. Now, using yeast as a model organism, researchers at the University of Pennsylvania School of Medicine are beginning to identify the molecular signals that could in part underlie that problem.

25 Aug 2010

SureGene collaborates with Medco Health Solutions to conduct REST study

SureGene, LLC and the Medco Research Institute, LLC, a wholly-owned subsidiary of Medco Health Solutions, Inc., today announced that they have entered into a novel investigative research collaboration to evaluate whether variation in genetic biomarkers previously identified by SureGene can help predict drug response for widely prescribed antipsychotic drugs in patients with serious mental illness.

25 Aug 2010

Prenatal exposure to atrazine leads to prostate inflammation in male rats

A new study shows that male rats prenatally exposed to low doses of atrazine, a widely used herbicide, are more likely to develop prostate inflammation and to go through puberty later than non-exposed animals. The research adds to a growing body of literature on atrazine, an herbicide predominantly used to control weeds and grasses in crops such as corn and sugar cane. Atrazine and its byproducts are known to be relatively persistent in the environment, potentially finding their way into water supplies.

25 Aug 2010

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

UK scientists at the University of Oxford have discovered that vitamin D can affect the activity of more than 200 genes of cells grown in the lab. Some of these genes are known from previous studies to be involved in diseases like diabetes and cancer.

24 Aug 2010

UNT Health Science Center analyzes DNA from unidentified human remains

Center for Human Identification at the University of North Texas Health Science Center (UNTHSC) analyzes DNA from unidentified human remains for law enforcement organizations and medical examiners across the country in an attempt to put a name to a body or victim. The result, in many cases, is resolution for family members who have spent years wondering about the fate of their loved one.

24 Aug 2010

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

Alnylam Pharmaceuticals, Inc.,a leading RNAi therapeutics company, announced today that it will make a total of 16 oral presentations at the American Chemical Society (ACS) Fall 2010 240th National Meeting & Exposition being held in Boston, Mass. from August 22-26, 2010.

24 Aug 2010

Medical Science News

Continuous boosting of natural painkiller shuts down brain cell receptor response

Bisphenol A chemical may shorten reproductive lifespan in women: Research

Human umbilical cord blood cells appear to protect astrocytes from cell death: Research

CRT, Bayer Schering Pharma partner to study new leptin antagonist peptides in gynaecological, oncological diseases

Vitamin D2 in AbM mushroom can neutralize oxidative stress: Research

Study identifies four genetic variants associated with ESRD disease in Chinese diabetic patients

Water improves health and reverses aging process

Agilent Technologies introduces SureSelect Human All Exon v2 Target Enrichment kit for cancer assay

Researchers identify specific gene responsible for Kuf's disease

Mayo researchers develop new laboratory cell lines to study anaplastic thyroid cancer

Fluoridation exposure during childhood prevents adult tooth loss

New TRIM5α-based treatments can knock out HIV in humans: Research

Water soluble extract of cinnamon reduces diabetes and heart disease risk

Increased levels of Oxytocin hormone fosters trust, increases generosity

Researchers identify molecular signals that impact male fertility: Research

SureGene collaborates with Medco Health Solutions to conduct REST study

Prenatal exposure to atrazine leads to prostate inflammation in male rats

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

UNT Health Science Center analyzes DNA from unidentified human remains

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Latest News